A Study of Pharmacodynamic and Genetic Parameters of Abira-DES Study Participants (NCT02217566) - Participants With Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone Acetate Following Unresponsive Treatment With Diethylstilbestrol

NCT04268628 · clinicaltrials.gov ↗

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration-resistant Prostate Cancer

Interventions

OTHER: Serum and plasma samples analysis

Sponsor

Janssen-Cilag Farmaceutica Ltda.